SKI-I, K-145, PF-543, and DMS exerted some beneficial effects on breast cancer. FTY720 has shown that the phosphorylated form accumulating in the nucleus inhibits class I HDACs and can cause ER to form in ER-negative breast cancer. Here, ESR1 is linked to breast carcinoma.